| Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports. | |
| | |
MedLine Citation:
|
PMID: 18000964 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review the literature on the use of atypical antipsychotics in anorexia nervosa of children and adolescents and to present three case reports on quetiapine treatment of this subgroup. METHOD: Review of the literature and case report. RESULTS: Several case reports and two small open-label trials, mainly in adults, observed beneficial effects of olanzapine on anorexic psychopathology. Only 16 case reports have been published on children and adolescents. Because of its lower propensity to induce weight gain quetiapine might be favourable with regard to patients' compliance. Our case reports revealed positive psychopathological effects and good tolerability of quetiapine in minors with severe anorexia nervosa. Careful titration and intense drug monitoring are recommended. DISCUSSION: In a small subset of patients with severe, treatment- resistant anorexia nervosa, extreme weight phobia, delusional body image disturbances or severe hyperactivity might be considered as indications for atypical antipsychotics. However, controlled studies are needed. |
| | |
Authors:
|
Claudia Mehler-Wex; Marcel Romanos; Julia Kirchheiner; Ulrike M E Schulze |
Related Documents
:
|
21087484 - Immunomodulatory dietary polysaccharides: a systematic review of the literature. 19425214 - Australian immigrant of the arachnid variety? 8961914 - Preliminary experience with low-dose methotrexate in fibroblastic rheumatism. 319204 - Naloxone-induced reversal of schizophrenic hallucinations. 6755064 - Immune complex orchitis in infertile men. immunoelectron microscopy of abnormal basemen... 9855134 - Ureterocolic fistula secondary to colonic diverticulitis. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: European eating disorders review : the journal of the Eating Disorders Association Volume: 16 ISSN: 1099-0968 ISO Abbreviation: Eur Eat Disord Rev Publication Date: 2008 Mar |
Date Detail:
|
Created Date: 2008-02-25 Completed Date: 2008-03-13 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9436977 Medline TA: Eur Eat Disord Rev Country: England |
Other Details:
|
Languages: eng Pagination: 100-8 Citation Subset: IM |
Copyright Information:
|
(c) 2007 John Wiley & Sons, Ltd and Eating Disorders Association |
Affiliation:
|
Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm, Steinhövelstr. 5, Ulm, Germany. claudia.mehler-wex@uniklinik-ulm.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Anorexia Nervosa / drug therapy*, psychology Antipsychotic Agents / therapeutic use* Benzodiazepines / therapeutic use Child Dibenzothiazepines / therapeutic use* Female Humans Risperidone / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 0/Dibenzothiazepines; 0/quetiapine; 106266-06-2/Risperidone; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Macrophages: an elusive yet emerging therapeutic target of atherosclerosis.
Next Document: Socio-demographic characteristics of eating disorder patients in an outpatient clinic: a descriptive...